Transcranial Focused Ultrasound (tFUS) for Individual Dosing
This study is testing a new way to use a device called Brainsonix Bx Pulsar machine tFUS. This device uses sound waves to stimulate the brain. Researchers want to find a simple way to know if the device is in the right spot and using the correct amount of stimulation for each person. They will see if the tFUS can temporarily create a small blind spot in your vision, called a scotoma. This scotoma would be used to figure out the lowest effective dose for you. The study is looking for 30 healthy volunteers between 18 and 70 years old with normal vision and hearing, and no history of neurological or mental health conditions. The study is currently unclear on its recruitment status.
- Study design
- This is an interventional study with 30 planned participants. It is not specified if it is randomized or blinded.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint, temporary scotoma, is measured during and immediately after (10 minutes) the tFUS procedure.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
tFUS Induced Transient Scotoma for Individual Dosing
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Temporary ScotomaDuring and immediately after (10 minutes) the tFUS
Production of a temporary Scotoma as assessed by visual field testing of briefly presented objects in different quadrants while staring at a central cross on a computer screen.